120 related articles for article (PubMed ID: 35940043)
21. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors.
Bruin MAC; de Vries N; Lucas L; Rosing H; Huitema ADR; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121925. PubMed ID: 31915109
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
24. Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies.
Llopis B; Bleibtreu A; Schlemmer D; Robidou P; Paccoud O; Tissot N; Noé G; Junot H; Luyt CÉ; Funck-Brentano C; Zahr N
Clin Chem Lab Med; 2021 Oct; 59(11):1800-1810. PubMed ID: 34243226
[TBL] [Abstract][Full Text] [Related]
25. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of 20(S)-protopanaxadiol and its three metabolites in rat plasma by LC-MS/MS: application to their pharmacokinetic studies.
Li JQ; Wang JF; Li J; Zhang SH; He D; Tong RS; She SY
Biomed Chromatogr; 2018 Aug; 32(8):e4252. PubMed ID: 29607527
[TBL] [Abstract][Full Text] [Related]
28. Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by LC-MS/MS--application to forensic and therapeutic drug monitoring cases.
Rust KY; Wilkens H; Kaiser R; Bregel D; Wilske J; Kraemer T
Ther Drug Monit; 2012 Dec; 34(6):729-35. PubMed ID: 23128911
[TBL] [Abstract][Full Text] [Related]
29. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
[TBL] [Abstract][Full Text] [Related]
30. LC-MS
Ma D; Ji Z; Cao H; Huang J; Zeng L; Yin L
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209012
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
32. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an LC-MS/MS method for determination of a novel anticancer agent (CPI-613) in human plasma.
Reddy NR; Reddy V; Boteju A; Boteju L; Voelker T; Liu S; Hu K
Bioanalysis; 2022 Mar; 14(5):253-266. PubMed ID: 35172610
[TBL] [Abstract][Full Text] [Related]
36. Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept.
Jacobs CM; Radosa JC; Wagmann L; Zimmermann JSM; Kaya AC; Aygün A; Edel T; Stotz L; Ismaeil M; Solomayer EF; Meyer MR
Anal Bioanal Chem; 2024 May; 416(12):2969-2981. PubMed ID: 38488952
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.
Turković L; Bočkor L; Ekpenyong O; Silovski T; Lovrić M; Crnković S; Nigović B; Sertić M
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631440
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a high-throughput method for the quantitative analysis of D-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic study.
Cesari N; Fontana S; Montanari D; Braggio S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):21-8. PubMed ID: 19945359
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
Parsons TL; Marzinke MA
J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]